在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Syndecan-1/CD138(SDC1) ELISA Kit

  • 中文名稱:
    人Syndecan-1/CD138(SDC1)酶聯(lián)免疫試劑盒
  • 貨號:
    CSB-E14983h
  • 規(guī)格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人Syndecan-1/CD138(SDC1)酶聯(lián)免疫試劑盒(CSB-E14983h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的SDC1含量。SDC1(Syndecan-1)是硫酸肝素蛋白多糖家族的重要成員,主要存在于上皮細胞,參與細胞粘附、信號轉導和腫瘤發(fā)生發(fā)展。研究顯示,SDC1通過調節(jié)細胞增殖、凋亡和遷移等過程,在多種腫瘤中發(fā)揮重要作用,是乳腺癌等腫瘤的潛在治療靶點。試劑盒檢測范圍為4.7 ng/mL-300 ng/mL,特別適用于腫瘤生物學、免疫調節(jié)機制或組織再生等基礎研究領域,為研究者探索SDC1在疾病發(fā)生發(fā)展中的分子作用提供可靠工具。本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    CD_antigen ELISA Kit; CD138 ELISA Kit; CD138 antigen ELISA Kit; heparan sulfate proteoglycan fibroblast growth factor receptor ELISA Kit; SDC ELISA Kit; Sdc1 ELISA Kit; SDC1_HUMAN ELISA Kit; SYND1 ELISA Kit; Syndecan 1 ELISA Kit; Syndecan ELISA Kit; syndecan proteoglycan 1 ELISA Kit; Syndecan-1 ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    4.7 ng/mL-300 ng/mL
  • 靈敏度:
    1.17 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Signal Transduction
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human SDC1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
     SampleSerum(n=4)
    1:1Average %86
    Range %82-91
    1:2Average %96
    Range %91-101
    1:4Average %94
    Range %88-99
    1:8Average %95
    Range %90-100
  • 回收率:
    The recovery of human SDC1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9693-99
    EDTA plasma (n=4)9084-96
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    3002.439 2.411 2.425 2.272
    1502.048 2.001 2.025 1.872
    751.635 1.547 1.591 1.438
    37.51.182 1.106 1.144 0.991
    18.750.843 0.781 0.812 0.659
    9.40.467 0.438 0.453 0.300
    4.70.282 0.274 0.278 0.125
    00.159 0.147 0.153  
  • 本試劑盒所含材料:
    • A micro ELISA plate ---The 96-well plate has been pre-coated with an anti-human SDC1 antibody. This dismountable microplate can be divided into 12 x 8 strip plates.
    • Two vials lyophilized standard ---Dilute a bottle of the standard at dilution series, read the OD values, and then draw a standard curve.
    • One vial Biotin-labeled SDC1 antibody (100 x concentrate) (120 μl/bottle) ---Act as the detection antibody.
    • One vial HRP-avidin (100 x concentrate) (120 μl/bottle) ---Bind to the detection antibody and react with the TMB substrate to make the solution chromogenic.
    • One vial Biotin-antibody Diluent (15 ml/bottle) ---Dilute the Biotin-antibody.
    • One vial HRP-avidin Diluent (15 ml/bottle) ---Dilute the HRP-avidin solution.
    • One vial Sample Diluent (50 ml/bottle)---Dilute the sample to an appropriate concentration.
    • One vial Wash Buffer (25 x concentrate) (20 ml/bottle) ---Wash away unbound or free substances.
    • One vial TMB Substrate (10 ml/bottle) ---Act as the chromogenic agent. TMB interacts with HRP, eliciting the solution turns blue.
    • One vial Stop Solution (10 ml/bottle) ---Stop the color reaction. The solution color immediately turns from blue to yellow.
    • Four Adhesive Strips (For 96 wells) --- Cover the microplate when incubation.
    • An instruction manual

    顯示更多

    收起更多

  • 本試劑盒不含材料:
    • A microplate reader capable of measuring absorbance at 450 nm, with the correction wavelength set at 540 nm or 570 nm.
    • An incubator can provide stable incubation conditions up to 37°C±5°C.
    • Centrifuge
    • Vortex
    • Squirt bottle, manifold dispenser, or automated microplate washer
    • Absorbent paper for blotting the microtiter plate
    • 50-300ul multi-channel micropipette
    • Pipette tips
    • Single-channel micropipette with different ranges
    • 100ml and 500ml graduated cylinders
    • Deionized or distilled water
    • Timer
    • Test tubes for dilution

    顯示更多

    收起更多

  • 數據處理:
  • 貨期:
    3-5 working days

引用文獻

產品評價

靶點詳情

  • 功能:
    Cell surface proteoglycan that bears both heparan sulfate and chondroitin sulfate and that links the cytoskeleton to the interstitial matrix. Regulates exosome biogenesis in concert with SDCBP and PDCD6IP.
  • 基因功能參考文獻:
    1. The research revealed identical overall epithelial Sdc1 expression in both breast carcinomas with no statistically significant difference in its stromal expression and confirmed the role of Sdc1 in the progression of both tumor types and in the development of ductal carcinoma's metastatic potential. PMID: 30151336
    2. Study demonstrated that miR494 is able to downregulate SDC1 expression, thereby inhibiting the progression of pancreatic cancer. PMID: 29956739
    3. High serum SDC1 expression is associated with chemotherapy-resistance in castration-resistant prostate cancer. PMID: 29628317
    4. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. PMID: 29850393
    5. evamisole inhibited CD138 expression and affected the levels of IL-6 in a dose-dependent manner. The results of the present study add new dimension to levamisole's mode of action as inhibitor of CD138 and IL-6 and as an antiapoptotic agent. PMID: 29798960
    6. serum level higher in control group than in early-onset or late-onset pre-eclampsia PMID: 28574293
    7. syndecan-1 levels were associated with not only the severity of illness and mortality but also disseminated intravascular coagulation development in sepsis, suggesting that syndecan-1 could be a predictive marker of disseminated intravascular coagulation PMID: 28843664
    8. our findings revealed that SDC1 suppressed EMT via the modulation of the ERK signaling pathway that, in turn, negatively affected the invasiveness of human oral cancer cells. Our results provided useful evidence about the potential use of SDC1 as a molecular target for therapeutic interventions in human oral cancer. PMID: 29484435
    9. The positive correlation between soluble Syndecan-1 levels and breast cancer tumor size in the present study highlights the importance of this molecule in the breast tumor progression and their significance as tumor biomarkers. PMID: 28382590
    10. our results identify the CD63-syntenin-1-ALIX complex as a key regulatory component in post-endocytic HPV trafficking. PMID: 27578500
    11. abrogation of nuclear translocation of syndecan-1 resulted in a set of changes clustering in distinct patterns, which highlighted the functional importance of nuclear syndecan-1 in hampering cell proliferation and the cell cycle PMID: 29216821
    12. findings support a key role for Sdc1 in modulating pulmonary protection by FFP after hemorrhagic shock. PMID: 28107214
    13. S1P induces advanced tumor phenotypes of hepatocellular carcinoma via establishing an MMP-7/syndecan-1/TGF-beta1 autocrine loop PMID: 27556509
    14. There was a close correlation between the expression of IL-17 and syndecan-1 in nasal mucosa epithelial cells, glandular epithelial cells, and inflammatory cells, suggesting that IL-17 and syndecan-1 may play a role, and interact with each other, in the pathogenesis of non- eosinophilic chronic rhinosinusitis with nasal polyps. PMID: 28585128
    15. the present study showed that serum Syndecan-1 might be a reliable marker for monitoring disease activity and renal activity in children with JSLE and lupus nephritis. PMID: 27838471
    16. The above suggest that radiation-mediated premature senescence and invasive tumor cells, alone or in combination, enhance SDC1 expression in breast stromal fibroblasts, a poor prognostic factor for cancer growth, and that TGF-beta plays a crucial role in this process. PMID: 27434331
    17. A syndecan-1 level >/=40 ng/mL identified trauma patients with significantly worse outcomes, despite admission physiology similar to those without the condition. PMID: 28579548
    18. MiR-331-3p-mediated miRNA maturation and enhanced epithelial-to-mesenchymal transition via effects on TGF-beta/Smad 4 and Dicer are essential for the development of prostate cancer mediated by syndecan-1. PMID: 26259043
    19. The heparanase/syndecan1 axis in gallbladder carcinoma cells plays an important role in the invasion and metastasis, thus providing a new therapeutic target. PMID: 28351285
    20. Syndecan-1 acts as a novel tissue biomarker and a modulator of CSC phenotype of triple negative IBC via the IL-6/STAT3, Notch and EGFR signaling pathways, thus emerging as a promising therapeutic target for IBC. PMID: 28270211
    21. Hepatitis C virus infection downregulates Synd-1 and upregulates Xylt 2 expression, likely contributing to a major glycocalyx reshuffle within days of infection. PMID: 27930836
    22. Soluble Sdc1 is significantly lower before the clinical onset of preeclampsia, with reduced expression of Sdc1 in the delivered placenta, suggesting a role for glycocalyx disturbance in preeclampsia pathophysiology. PMID: 27299886
    23. Heparanase has emerged as a major regulator of cancer by degrading heparan sulfate thereby influencing multiple signaling pathways that control gene expression, syndecan shedding and cell behavior. (Review) PMID: 27758044
    24. Study provides robust evidence in favor of the additional baseline soluble CD138 prognostic value for OS, in mCRC patients. A simple biological scoring system is proposed including LDH and CD138 binary status values. PMID: 27472156
    25. it is not appropriate to assume that CD138 expression in urothelial carcinomas is specific for plasmacytoid variants PMID: 27305940
    26. epithelial cytoplasmic expression of maspin and CD138 may have a significant role in tumorigenesis in ovarian high-grade serous carcinomas and clear cell carcinomas; these markers may regulate tumor cell proliferation, and their significant correlation to each other may suggest that CD138 probably induces maspin expression to protect tumor growth factors from being lysed by proteolytic enzymes PMID: 26526579
    27. High syndecan level is associated with sepsis. PMID: 26953518
    28. Systemic sclerosis (SSc) patients with elevated serum syndecan-1 levels had higher prevalence of telangiectasia, elevated right ventricular systolic pressure and decreased diffuse capacity of the lung for carbon monoxide than those with normal levels. Therefore, soluble syndecan-1 may be related to the development of proliferative vasculopathy in SSc patients. PMID: 26076711
    29. in colorectal adenomas, the heparanase-1 does not participate in syndecan-1 degradation; the heparanase-2 does not stimulate syndecan-1 degradation by the action of heparanase-1, and the heparanase-2 may be involved in the modulation of the heparanase-1 activity. PMID: 26972718
    30. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts. PMID: 26460958
    31. The new markers were able to identify a clonal CD138-negative population as minimal residual disease in the bone marrow and peripheral blood of MM patients. PMID: 26729247
    32. miR-145 suppresses syndecan-1 and, by this mechanism, up-regulates stem cell factors and induces cell senescence and differentiation. PMID: 26514209
    33. The results suggest that Sdc1 may modulate fibronectin fibrillogenesis and/or alter cell morphology during ECM production through alphavbeta3 integrin, thereby mediating ECM fiber alignment. PMID: 26909794
    34. Syndecan-1 on epithelial tumor cells promotes MIF binding and MIF-mediated cell migration. This may represent a relevant mechanism through which MIF enhances tumor cell motility and metastasis. PMID: 26852939
    35. SULF1 levels are lower in pleural malignancies compared to benign conditions and inversely correlate with the amounts of syndecan-1, suggesting important roles for syndecan-1 and SULF1 in malignant mesothelioma. PMID: 26210886
    36. Our study indicates that SDC1 expressed by the bone marrow microenvironment is involved in angiogenesis in MM. PMID: 25353275
    37. miR-302a plays a key role in inhibition of ovarian cancer cell proliferation, and enhancing apoptosis by targeting SDC1. PMID: 26191180
    38. The concentration of syndecan-1, a marker of glycocalyx damage measured during ED admission, is valuable in assessing the risk of developing AKI and in-hospital mortality. PMID: 25891890
    39. Sdc-1 may act as a modulator of ESC apoptosis and probably invasion depth as a crucial factor for successful pregnancy. PMID: 25830352
    40. Elevated levels of soluble CD138/Sdc-1 in older bladder cancer patients and those with muscular invasion sheds some light on the mechanisms of the disease invasion. PMID: 25115297
    41. demonstrate that HER2 is captured via a site, comprised of amino acids 210-240, in the extracellular domain of human Sdc1, and EGFR is captured via an extracellular site comprised of amino acids 87-131 in human Sdc4 PMID: 26350464
    42. stromal changes in the expression of SDC-1 may originate from the stroma and contribute to the pathogenesis and metastatic potential of epithelial ovarian carcinoma PMID: 26513873
    43. syndecan-1 has a role in glycocalyx shedding and is increased in patients with end-stage liver disease; ischemia-reperfusion injury during OLT further exacerbates glycocalyx shedding PMID: 25757215
    44. Data indicate that the extracellular and cytoplasmic domains of syndecans 1/2/3/4 are intrinsically disordered regions. PMID: 24956062
    45. HPV16 particles binds to heparan sulfate and syndecan-1 molecules present in the extracellular matrix. PMID: 26289843
    46. syndecan-1 may have a role as a biological and prognostic marker in patients with triple-positive breast carcinomas PMID: 25273930
    47. our findings identify heparanase as a modulator of the syndecan-syntenin-ALIX pathway, fostering endosomal membrane budding and the biogenesis of exosomes by trimming the heparan sulfate chains on syndecans PMID: 25732677
    48. Serum SDC-1 levels are increased in systemic lupus erythematosus patients with nephritis, indicating that SDC-1 might be a useful serum biomarker for active LN. PMID: 25512478
    49. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma PMID: 25589885
    50. syndecan-1 in pleural effusions predicted a survival difference for patients with pleural metastatic disease and malignant mesothelioma. PMID: 25147801

    顯示更多

    收起更多

  • 亞細胞定位:
    Membrane; Single-pass type I membrane protein. Secreted. Secreted, extracellular exosome.
  • 蛋白家族:
    Syndecan proteoglycan family
  • 數據庫鏈接:

    HGNC: 10658

    OMIM: 186355

    KEGG: hsa:6382

    STRING: 9606.ENSP00000254351

    UniGene: Hs.224607



主站蜘蛛池模板: 一个人看的www免费视频在线观看| 久久人搡人人玩人妻精品| 丰满人妻在公车被猛烈进入电影| 丰满人妻被中出中文字幕| 亚洲精品国产嫩草在线观看东京热| 不卡高清av手机在线观看| 国产农村妇女高潮大叫| 国产亚洲精品久久久久蜜臀| 欧美性xxxxx极品少妇| 日韩高清成片免费视频| 日本熟妇厨房bbw| 中文字幕人妻熟女在线| 久久99国产精品成人| 国产精品亚洲玖玖玖在线观看| av制服丝袜白丝国产网站| 免费人妻av无码专区| 在线观看片免费人成视频播放| 先锋影音人妻啪啪va资源网站| 亚洲熟妇丰满多毛xxxx| 妺妺窝人体色www在线小说| 色五月丁香五月综合五月4438| 四虎影视无码永久免费 | 在线天堂资源www| 隔壁人妻偷人bd中字| 九九综合九色综合网站| 免费看女人与公拘交酡过程| 国产内射爽爽大片| 人妻奶水人妻系列| 国产天美传媒性色av出轨| 日本 精品 高清不卡| 国产亚洲精品自在久久| 国产女人与公拘交在线播放| 成人免费网站视频www| 亚洲国产精品久久久久久无码| 天天爽夜夜爽夜夜爽精品视频| 国产av无码专区亚洲草草| 亚洲久久久久久中文字幕| 亚洲乱亚洲乱少妇无码99p| 亚洲国产av天码精品果冻传媒| 中文字幕亚洲码在线| 亚洲色偷偷偷综合网|